# Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults

> **NCT03965962** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 640 (actual)

## Conditions studied

- Rabies (Healthy Volunteers)

## Interventions

- **BIOLOGICAL:** VRVg-2
- **BIOLOGICAL:** Purified Inactivated Rabies Vaccine
- **BIOLOGICAL:** Human Diploid Cell Vaccine (HDCV)
- **BIOLOGICAL:** Rabies immune globulin (human)

## Key facts

- **NCT ID:** NCT03965962
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2020-12-22
- **Final completion:** 2021-07-01
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03965962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03965962, "Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03965962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*